Comparing Worldwide, National, and Independent Notifications about Adverse Drug Reactions Due to COVID-19 Vaccines
The rapid development of effective vaccines against COVID-19 is an extraordinary achievement. However, no medical product can ever be considered risk-free. Several countries have a pharmacovigilance system that detects, assesses, understands, and prevents possible adverse effects of a drug. To benef...
Main Authors: | Francesco Branda, Davide Tosi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Information |
Subjects: | |
Online Access: | https://www.mdpi.com/2078-2489/13/7/329 |
Similar Items
-
Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana
by: Peter Yamoah, et al.
Published: (2019-03-01) -
Farmacovigilancia de vacunas y su aplicación en Chile
by: Adiela Saldaña, et al.
Published: (2020-05-01) -
Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017
by: Pasquale Stefanizzi, et al.
Published: (2020-08-01) -
Pharmacovigilance in Brazil: The Government Monitoring of Adverse Events Reported from COVID-19 Vaccine—A Narrative Review
by: Mariana Carvalho de Moraes, et al.
Published: (2024-02-01) -
Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy
by: Niccolò Lombardi, et al.
Published: (2019-08-01)